Results 251 to 260 of about 62,786 (347)

Time-varying cost-effectiveness analysis of sodium-glucose cotransporter-2 inhibitors in Chinese patients with heart failure and reduced ejection fraction: A microsimulation of the real-world population. [PDF]

Front Pharmacol
Zou X, He X, Shi Q, Wang S, Li N, Zhou Y, Hu M, Luo L, Shen Y, Zhu Y, Lang CC, Zhu Z, Tian H, Li S.   +13 more
europepmc   +1 more source

Preventive Effect of Upland Pigmented Potatoes Against LPS‐Induced Inflammation in THP‐1 Macrophages

Molecular Nutrition &Food Research, EarlyView.
The anti‐inflammatory activity of extracts from three commercial potato varieties cultivated upland was investigated on THP‐1 macrophages insulted with LPS. While the chlorogenic acid (CGA)‐rich extract from Kennebec reduced inflammation only at supraphysiological doses, carotenoid‐rich Desirèe and anthocyanin (ACN)‐rich Bleuet decreased TNF‐α, IL‐1β ...
Marta Toccaceli, Alessandra Marinelli, Federico Ballabio, Laura Bassolino, Roberto Lo Scalzo, Bruno Parisi, Daniela Pacifico, Federica Nicoletti, Carlo Camilloni, Giuseppe Mandolino, Katia Petroni   +10 more
wiley   +1 more source

Antihyperglycemic Effect of T-1095 via Inhibition of Renal Na+-Glucose Cotransporters in Streptozotocin-Induced Diabetic Rats.

, 2000
Akira Oku, Kiichiro Ueta, Kenji Arakawa, Tomomi Kano-Ishihara, Mamoru Matsumoto, Tetsuya Adachi, Koichiro Yasuda, Kinsuke Tsuda, Akira Saito   +8 more
openalex   +2 more sources

Risk of acute kidney injury in dapagliflozin users with type 2 diabetes: A nationwide propensity score‐matched cohort study in Korea

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, EarlyView.
Abstract Background Several previous studies have identified a potential risk of acute kidney injury (AKI) associated with sodium‐glucose cotransporter‐2 (SGLT‐2) inhibitors, based on adverse event reports. However, recent European observational studies have shown conflicting results.
Hee‐Jin Kim, Heehyun Won, Suvin Park, Hui‐Eon Lee, Haerin Cho, Jeong Ah. Kim, Na‐Young Jeong, HoJin Shin, Ye‐Jee Kim, Nam‐Kyong Choi   +9 more
wiley   +1 more source

Efficacy of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on proteinuria and weight in a diabetes cohort. [PDF]

World J Diabetes
Lu DF, Zheng R, Li A, Zhang JQ.
europepmc   +1 more source

Development and Validation of a Capillary Electrophoresis Coupled to Mass Spectrometry Pipeline for Comparable Assessment of the Plasma Peptidome

PROTEOMICS, EarlyView.
ABSTRACT Although capillary electrophoresis coupled to mass spectrometry (CE‐MS) holds promise for urinary peptide profiling, only a limited number of studies have used CE‐MS to study plasma peptides. Here we describe the establishment of a workflow, including sample preparation, CE‐MS analysis, data processing and normalization optimized for the ...
Lucie Fernandez, Benjamin Breuil, Carine Froment, Mouhamed Seye, Babacar Sylla, Marina Estanco, Adeline Chaubet, Eléonore Delecroix, Karima Chaoui, Jeanne Pierrette Vu, Serban Ardeleanu, Stanislas Faguer, Odile Burlet‐Schiltz, Bénédicte Buffin‐Meyer, Joost P. Schanstra, Julie Klein   +15 more
wiley   +1 more source

Real-world evidence on the association of novel antidiabetic medication use with cancer risk and protective effects: a systematic review and network meta-analysis. [PDF]

Ther Adv Drug Saf
Kenawy AS, Liu YS, Aiyeolemi A, Okoye G, Park C.   +4 more
europepmc   +1 more source

Comparative Proteomics of Salinity Stress Responses in Fish and Aquatic Invertebrates

PROTEOMICS, EarlyView.
ABSTRACT Fluctuating salinity is symptomatic of climate change challenging aquatic species. The melting of polar ice, rising sea levels, coastal surface and groundwater salinization, and increased evaporation in arid habitats alter salinity worldwide. Moreover, the frequency and intensity of extreme weather events such as rainstorms and floods increase,
Maxime Leprêtre, Jens Hamar, Monica B. Urias, Dietmar Kültz   +3 more
wiley   +1 more source

Sodium-glucose cotransporter 2 (SGLT2) inhibitors and risk of chronic kidney disease-mineral and bone disorders in patients with type 2 diabetes mellitus and stage 1-3 chronic kidney disease. [PDF]

CMAJ
Tsai DH, Chuang AT, Liu KH, Shao SC, Lai EC.   +4 more
europepmc   +1 more source